The University of Chicago Header Logo

Benjamin Derman

Concepts (181)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
46
2026
372
17.140
Why?
Neoplasm, Residual
13
2025
205
4.350
Why?
Hematopoietic Stem Cell Transplantation
13
2026
979
3.470
Why?
Dexamethasone
12
2026
318
2.650
Why?
Oligopeptides
10
2026
205
2.420
Why?
Antineoplastic Combined Chemotherapy Protocols
17
2026
2666
2.130
Why?
Maintenance Chemotherapy
4
2025
96
1.490
Why?
Immunotherapy, Adoptive
10
2026
336
1.440
Why?
Transplantation, Autologous
11
2026
398
1.370
Why?
Antibodies, Monoclonal
4
2025
1422
1.340
Why?
Peripheral Nervous System Diseases
2
2022
94
1.320
Why?
Antineoplastic Agents
4
2026
2386
1.110
Why?
Mass Spectrometry
2
2025
189
1.080
Why?
Myeloma Proteins
2
2025
36
1.070
Why?
Hematologic Neoplasms
2
2022
384
1.000
Why?
Humans
65
2026
98799
0.980
Why?
Paraproteinemias
2
2025
19
0.930
Why?
Antibodies, Bispecific
2
2024
51
0.930
Why?
Waldenstrom Macroglobulinemia
2
2024
11
0.920
Why?
Geriatric Assessment
4
2024
193
0.910
Why?
Hematology
1
2026
37
0.910
Why?
Monoclonal Gammopathy of Undetermined Significance
2
2022
10
0.900
Why?
Premedication
1
2024
57
0.840
Why?
Ambulatory Care
1
2026
203
0.830
Why?
Serotonin and Noradrenaline Reuptake Inhibitors
1
2021
2
0.690
Why?
Duloxetine Hydrochloride
1
2021
3
0.690
Why?
Aged
23
2026
21986
0.690
Why?
Practice Guidelines as Topic
3
2026
1116
0.690
Why?
Middle Aged
24
2026
29642
0.670
Why?
Clinical Decision-Making
2
2020
306
0.650
Why?
Agammaglobulinemia
1
2020
21
0.640
Why?
Amyloidosis
1
2022
136
0.620
Why?
Cancer Survivors
1
2021
110
0.600
Why?
Daunorubicin
1
2019
77
0.600
Why?
Disease Management
3
2026
378
0.580
Why?
T-Lymphocytes
6
2026
1335
0.580
Why?
Cytarabine
1
2019
218
0.570
Why?
Interdisciplinary Communication
1
2019
137
0.570
Why?
Bacterial Infections
1
2020
184
0.570
Why?
Male
24
2026
47475
0.550
Why?
Remission Induction
1
2019
764
0.520
Why?
B-Cell Maturation Antigen
3
2026
21
0.510
Why?
Diabetes Insipidus, Nephrogenic
1
2017
1
0.500
Why?
Female
24
2026
51997
0.500
Why?
Preoperative Care
1
2019
420
0.500
Why?
Bendamustine Hydrochloride
1
2017
10
0.500
Why?
Adult
15
2026
29698
0.490
Why?
Patient Care Team
1
2019
318
0.490
Why?
T-Lymphocytes, Regulatory
1
2020
358
0.480
Why?
Leukemia, Myeloid, Acute
2
2020
850
0.480
Why?
Budd-Chiari Syndrome
1
2015
8
0.450
Why?
Stem Cell Transplantation
3
2021
196
0.440
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2019
445
0.440
Why?
Health Knowledge, Attitudes, Practice
1
2020
608
0.440
Why?
Aged, 80 and over
7
2026
7461
0.430
Why?
Attitude of Health Personnel
1
2020
688
0.430
Why?
Precision Medicine
1
2019
512
0.420
Why?
Immunoglobulin Light-chain Amyloidosis
2
2025
31
0.420
Why?
Practice Patterns, Physicians'
1
2020
669
0.420
Why?
Treatment Outcome
9
2026
9806
0.390
Why?
Kaplan-Meier Estimate
3
2020
909
0.380
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2025
83
0.380
Why?
Physicians
1
2020
687
0.380
Why?
Cell-Free Nucleic Acids
2
2026
116
0.370
Why?
Venous Thrombosis
1
2015
265
0.370
Why?
Medical Oncology
2
2026
426
0.340
Why?
Flow Cytometry
2
2024
722
0.310
Why?
Surveys and Questionnaires
3
2026
3058
0.310
Why?
Prognosis
4
2026
4139
0.280
Why?
Proportional Hazards Models
2
2020
925
0.270
Why?
High-Throughput Nucleotide Sequencing
2
2024
588
0.270
Why?
Carcinoma, Non-Small-Cell Lung
1
2017
1177
0.260
Why?
5-Methylcytosine
2
2026
134
0.260
Why?
Thalidomide
2
2024
57
0.250
Why?
Leukemia, Plasma Cell
1
2025
2
0.220
Why?
Outpatients
1
2026
107
0.220
Why?
Central Nervous System Neoplasms
1
2026
104
0.210
Why?
Quality of Life
2
2024
1904
0.210
Why?
Injections, Subcutaneous
1
2024
142
0.210
Why?
Lung Neoplasms
1
2017
2474
0.200
Why?
Disease-Free Survival
2
2023
1196
0.200
Why?
Withholding Treatment
1
2024
130
0.200
Why?
CD3 Complex
1
2023
137
0.190
Why?
Hydrazines
1
2023
36
0.190
Why?
Hypercalcemia
1
2023
60
0.190
Why?
Lymphoma, B-Cell
1
2024
110
0.190
Why?
Imides
1
2022
27
0.180
Why?
Consensus
1
2024
308
0.180
Why?
Proteasome Inhibitors
1
2022
52
0.180
Why?
Bortezomib
1
2022
83
0.180
Why?
Triazoles
1
2023
118
0.180
Why?
Melphalan
1
2022
98
0.180
Why?
Bone Marrow
1
2024
419
0.180
Why?
Cyclophosphamide
1
2022
285
0.170
Why?
Immunotherapy
2
2025
831
0.170
Why?
Health Services Accessibility
1
2026
548
0.170
Why?
Lymphoma, Large B-Cell, Diffuse
1
2023
197
0.170
Why?
Bone Marrow Examination
1
2020
40
0.160
Why?
Immunoglobulins, Intravenous
1
2020
67
0.150
Why?
Health Planning Guidelines
1
2019
25
0.150
Why?
Healthcare Disparities
1
2026
558
0.150
Why?
Biomarkers, Tumor
2
2026
1786
0.150
Why?
Asparaginase
1
2019
38
0.150
Why?
Philadelphia Chromosome
1
2019
48
0.150
Why?
Health Care Surveys
1
2020
282
0.150
Why?
Health Plan Implementation
1
2019
62
0.150
Why?
Positron Emission Tomography Computed Tomography
1
2020
108
0.150
Why?
Patient Reported Outcome Measures
1
2022
337
0.150
Why?
Reference Standards
1
2019
147
0.150
Why?
Standard of Care
1
2019
71
0.140
Why?
Chromosome Aberrations
1
2020
353
0.140
Why?
Allografts
1
2019
221
0.140
Why?
Sex Characteristics
1
2020
353
0.130
Why?
Polyethylene Glycols
1
2019
383
0.130
Why?
Transplantation, Homologous
1
2019
1029
0.130
Why?
Palliative Care
1
2019
291
0.130
Why?
Cognitive Dysfunction
1
2020
211
0.130
Why?
Sex Factors
1
2020
1144
0.130
Why?
Pilot Projects
1
2020
978
0.120
Why?
Leukocyte Count
1
2017
215
0.120
Why?
Neoplasms
2
2023
3382
0.120
Why?
Rituximab
1
2017
138
0.120
Why?
Time Factors
3
2020
5586
0.120
Why?
Antibodies, Monoclonal, Humanized
1
2022
1105
0.120
Why?
Sensitivity and Specificity
1
2020
1946
0.120
Why?
Prospective Studies
2
2026
4837
0.120
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
150
0.110
Why?
Patient Selection
1
2019
725
0.110
Why?
Retrospective Studies
4
2023
11104
0.110
Why?
Body Weight
1
2017
457
0.110
Why?
Splanchnic Circulation
1
2015
14
0.110
Why?
Disease Progression
1
2020
1621
0.110
Why?
Neutrophils
1
2017
346
0.110
Why?
Lymphocytes
1
2017
461
0.110
Why?
Serial Publications
1
2014
2
0.100
Why?
Journal Impact Factor
1
2014
18
0.100
Why?
United States
2
2026
8387
0.100
Why?
Science
1
2014
39
0.100
Why?
Reproduction
1
2014
212
0.090
Why?
Skin Neoplasms
1
2013
638
0.070
Why?
Child
1
2019
7771
0.070
Why?
Neoplasm Recurrence, Local
2
2026
1538
0.060
Why?
Risk Factors
2
2015
6295
0.060
Why?
Ontario
1
2026
32
0.060
Why?
Cell Transplantation
1
2023
46
0.050
Why?
Immunoglobulin G
1
2025
481
0.050
Why?
Recurrence
1
2026
1274
0.050
Why?
Fluorodeoxyglucose F18
1
2023
146
0.050
Why?
Adrenal Insufficiency
1
2022
23
0.050
Why?
Young Adult
1
2015
7598
0.040
Why?
Vaccines, Synthetic
1
2022
61
0.040
Why?
Tumor Burden
1
2023
330
0.040
Why?
Combined Modality Therapy
1
2026
1754
0.040
Why?
Adolescent
1
2015
10168
0.040
Why?
Antibody Formation
1
2022
173
0.040
Why?
Immunity, Cellular
1
2022
187
0.040
Why?
Receptors, Antigen, T-Cell
1
2024
454
0.040
Why?
Randomized Controlled Trials as Topic
1
2026
995
0.040
Why?
Antineoplastic Agents, Immunological
1
2024
238
0.040
Why?
Autografts
1
2020
38
0.040
Why?
Smoldering Multiple Myeloma
1
2020
4
0.040
Why?
Programmed Cell Death 1 Receptor
1
2022
201
0.040
Why?
Antibodies, Viral
1
2022
342
0.040
Why?
Molecular Diagnostic Techniques
1
2020
74
0.040
Why?
Neoplastic Cells, Circulating
1
2020
78
0.040
Why?
Vaccination
1
2022
328
0.040
Why?
Population Surveillance
1
2020
218
0.040
Why?
Activities of Daily Living
1
2020
214
0.040
Why?
Breast Neoplasms
1
2013
3303
0.040
Why?
Global Health
1
2020
216
0.040
Why?
Diagnostic Imaging
1
2020
468
0.030
Why?
Clinical Trials as Topic
1
2020
1128
0.030
Why?
PubMed
1
2014
16
0.030
Why?
Reproducibility of Results
1
2020
2799
0.030
Why?
Phenotype
1
2020
2673
0.020
Why?
Sunlight
1
2013
27
0.020
Why?
Postmenopause
1
2013
109
0.020
Why?
Research
1
2014
258
0.020
Why?
Women's Health
1
2013
120
0.020
Why?
Vitamin D
1
2013
287
0.020
Why?
Cohort Studies
1
2013
3242
0.010
Why?
Derman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (181)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_